InsidersTradesSigma
Follow the Mankind Pharma Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Mankind Pharma Limited has logged 3 public disclosures. Market capitalisation: €1,019.9bn. The latest transaction was reported on 9 February 2024 (Sale). Among the most active insiders: Arjun Juneja. All data is accessible without an account.
Analysts rate Mankind Pharma Limited Buy (bullish), based on 19 analysts. Average price target: ₹2,675.37.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Mankind Pharma Limited is an Indian company focused on the healthcare and pharmaceutical sector. It specializes in the research, development, and marketing of generic drugs and pharmaceutical products.